AIM Block Admission Return / Total Voting Rights

RNS Number : 6728D
MaxCyte, Inc.
20 February 2020




Please ensure the entries on this return are typed


a. Name of company


MaxCyte, Inc.


b. Name of scheme(s)


MaxCyte Long Term Incentive Plan


c. Period of return:


From  17 November 2018    To  20 February 2020


d. Number and class of securities not issued under scheme


415,759 ordinary shares of common stock of $0.01 each


e. Number of shares issued under scheme during period


96,496 ordinary shares of common stock of $0.01 each


f. Balance under the scheme not yet issued at the end of the period.


319,263 ordinary shares of common stock of $0.01 each


g. Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission; If additional blocklisting application have been made, under this scheme, since the original listing application please also state the number of shares and the date(s) of admission.


1,000,000 ordinary shares of common stock of $0.01 each on 5 May 2017


Please confirm your total issued share capital as at the end of this period.

(If you hold any shares in Treasury state the figure separately);


57,403,583 (51,444,847 MXCT.L and 5,958,736 MXCS.L)



Treasury shares (if applicable) …Nil….


h. Contact name and telephone number for queries;


Doug Doerfler, Chief Executive Officer

Ron Holtz, Chief Financial Officer

+1 301 944 1660




20 February 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit
UK 100

Latest directors dealings